Sanara Medtech
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $21,671 | $20,158 | $18,536 | $17,689 |
Gross Profit | 19,679 | 18,150 | 15,541 | 14,806 |
EBITDA | -851 | -1,779 | -426 | -1,086 |
EBIT | -1,955 | -2,884 | -1,531 | -2,180 |
Net Income | -2,857 | -3,504 | -1,764 | -237 |
Net Change In Cash | 21,671 | 20,158 | 18,536 | 17,689 |
Free Cash Flow | 2,041 | -1,470 | -1,660 | -902 |
Cash | 16,277 | 6,150 | 2,828 | 5,147 |
Basic Shares | 8,517 | 8,468 | 8,419 | 8,535 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $64,989 | $45,842 | $24,143 | $15,586 |
Gross Profit | 57,137 | 39,481 | 21,832 | 13,970 |
EBITDA | -289 | -11,850 | -7,221 | -4,024 |
EBIT | -3,964 | -14,485 | -7,993 | -4,433 |
Net Income | -4,303 | -8,092 | -7,305 | -4,382 |
Net Change In Cash | 64,989 | 45,842 | 24,143 | 15,586 |
Cost of Revenue | -9,693 | -6,156 | ||
Free Cash Flow | -3,510 | -6,301 | -5,564 | -5,678 |
Cash | 5,147 | 8,958 | 18,652 | 455 |
Basic Shares | 8,278 | 7,906 | 7,341 | 5,734 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.34 |
2024-06-30 | -$0.41 |
2024-03-31 | -$0.21 |
2023-12-31 | -$0.03 |
